XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings (accumulated deficit)
Retained earnings (accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive (loss)
Balance, beginning of period (in shares) at Dec. 31, 2019     79,599          
Balance, beginning of period at Dec. 31, 2019 $ 539,010   $ 796 $ 140,523   $ 410,919   $ (13,228)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cumulative-effect adjustment from adoption of ASU 2020-06, net Accounting Standards Update 2020-06 [Member]              
Equity component of convertible senior notes, net $ 61,604     61,604        
Repurchase of common stock (in shares)     (278)          
Repurchase of common stock (28,274)   $ (3) (28,271)        
Issuance of common stock for stock compensation plans (in shares)     1,536          
Issuance of common stock for stock compensation plans (75,562)   $ 16 (75,578)        
Issuance of common stock under the employee stock purchase plan (in shares)     33          
Issuance of common stock under the employee stock purchase plan 3,039     3,039        
Stock-based compensation 103,115     103,115        
Cash dividends declared (9,667)         (9,667)    
Other comprehensive (loss) income 10,280             10,280
Net (loss) (61,373)         (61,373)    
Balance, end of period (in shares) at Dec. 31, 2020     80,890          
Balance, end of period at Dec. 31, 2020 542,172 $ (52,205) $ 809 204,432 $ (61,604) 339,879 $ 9,399 (2,948)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Repurchase of common stock (in shares)     (432)          
Repurchase of common stock (53,610)   $ (5) (53,605)        
Issuance of common stock for stock compensation plans (in shares)     1,153          
Issuance of common stock for stock compensation plans (69,925)   $ 12 (69,937)        
Issuance of common stock under the employee stock purchase plan (in shares)     101          
Issuance of common stock under the employee stock purchase plan 10,554   $ 1 10,553        
Stock-based compensation 115,971     115,971        
Cash dividends declared (9,789)         (9,789)    
Other comprehensive (loss) income (4,040)             (4,040)
Net (loss) $ (63,040)         (63,040)    
Balance, end of period (in shares) at Dec. 31, 2021 81,712   81,712          
Balance, end of period at Dec. 31, 2021 $ 416,088   $ 817 145,810   276,449   (6,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Repurchase of common stock (in shares)     (280)          
Repurchase of common stock (24,508)   $ (2) (24,506)        
Issuance of common stock for stock compensation plans (in shares)     754          
Issuance of common stock for stock compensation plans (20,620)   $ 7 (20,627)        
Issuance of common stock under the employee stock purchase plan (in shares)     250          
Issuance of common stock under the employee stock purchase plan 9,172   $ 2 9,170        
Stock-based compensation 122,229     122,229        
Cash dividends declared (9,854)     (2,474)   (7,380)    
Other comprehensive (loss) income (16,082)             (16,082)
Net (loss) $ (345,582)         (345,582)    
Balance, end of period (in shares) at Dec. 31, 2022 82,436   82,436          
Balance, end of period at Dec. 31, 2022 $ 130,843   $ 824 $ 229,602   $ (76,513)   $ (23,070)